Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Depreciation and Depletion (2021 - 2025)

Strata Critical Medical (SRTA) has disclosed Depreciation and Depletion for 5 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 97.42% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2025, up 87.51% year-over-year, with the annual reading at $4.3 million for FY2025, 114.8% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $1.5 million at Strata Critical Medical, up from $1.1 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $1.5 million in Q4 2025, with the low at $79000.0 in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $603571.4, with a median of $541500.0 recorded in 2024.
  • The sharpest move saw Depreciation and Depletion soared 184.25% in 2024, then surged 63.35% in 2025.
  • Over 5 years, Depreciation and Depletion stood at $137000.0 in 2021, then rose by 8.03% to $148000.0 in 2022, then skyrocketed by 84.46% to $273000.0 in 2023, then skyrocketed by 184.25% to $776000.0 in 2024, then skyrocketed by 97.42% to $1.5 million in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $1.5 million, $1.1 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.